Together, these data support a proteostasis-first adaption in which neurons activate quality-control programs while transcriptionally reducing MAPT and allied neuronal demands, offering transcription-factor targets and a framework for modulating tau homeostasis relevant to Alzheimer’s disease and related tauopathies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.